Ken Griffin Accelerate Diagnostics, Inc Call Options Transaction History

Citadel Advisors LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	SELL	$0.64 - $1.03 $2,304 - $3,708	-3,600 Reduced 61.02%	2,300 $1,000
Q1 2023 May 15, 2023	SELL	$0.46 - $0.77 $736 - $1,232	-1,600 Reduced 21.33%	5,900 $4,000
Q4 2022 Feb 14, 2023	SELL	$0.51 - $17.1 $13,668 - $458,280	-26,800 Reduced 78.13%	7,500 $5,000
Q3 2022 Nov 14, 2022	BUY	$1.01 - $17.0 $4,444 - $74,800	4,400 Added 14.72%	34,300 $52,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $168M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.